🇺🇸 FDA
Pipeline program

Calquence 100 mg film-coated tablets, ACALABRUTINIB

SAKK 38/19

Phase 2 small_molecule active

Quick answer

Calquence 100 mg film-coated tablets, ACALABRUTINIB for Disseminated large B-cell lymphoma is a Phase 2 program (small_molecule) at Cancer Prevention Pharma (Ireland) Limited with 1 ClinicalTrials.gov record(s).

Program details

Company
Cancer Prevention Pharma (Ireland) Limited
Indication
Disseminated large B-cell lymphoma
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials